DK151884C - Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf

Info

Publication number: DK151884C
Authority: DK; Denmark
Prior art keywords: imidazolylalkyl; incidental; analogue; preparation; acid addition
Prior art date: 1979-03-07

Application number

DK042580A

Other languages

English (en)

Other versions

DK151884B (da

DK42580A (da

Inventor

Peter Edward Cross

Roger Peter Dickinson

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-03-07

Filing date

1980-01-31

Publication date

1988-06-13

1980-01-31 Application filed by Pfizer filed Critical Pfizer

1980-09-08 Publication of DK42580A publication Critical patent/DK42580A/da

1988-01-11 Publication of DK151884B publication Critical patent/DK151884B/da

1988-06-13 Application granted granted Critical

1988-06-13 Publication of DK151884C publication Critical patent/DK151884C/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK042580A 1979-03-07 1980-01-31 Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf DK151884C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB7908123		1979-03-07
GB7908123		1979-03-07

Publications (3)

Publication Number	Publication Date
DK42580A DK42580A (da)	1980-09-08
DK151884B DK151884B (da)	1988-01-11
DK151884C true DK151884C (da)	1988-06-13

Family

ID=10503707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK042580A DK151884C (da)	1979-03-07	1980-01-31	Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf

Country Status (36)

Country	Link
US (1)	US4273782A (da)
JP (1)	JPS55133380A (da)
KR (1)	KR850000760B1 (da)
AR (1)	AR227015A1 (da)
AT (1)	AT375366B (da)
AU (1)	AU516957B2 (da)
BE (1)	BE882113A (da)
CA (1)	CA1120479A (da)
CH (1)	CH649546A5 (da)
CS (1)	CS253702B2 (da)
DD (1)	DD149525A5 (da)
DE (1)	DE3008632A1 (da)
DK (1)	DK151884C (da)
ES (2)	ES489220A0 (da)
FI (1)	FI66860C (da)
FR (1)	FR2450832A1 (da)
GR (1)	GR67237B (da)
HK (1)	HK89884A (da)
HU (1)	HU184727B (da)
IE (1)	IE49542B1 (da)
IL (1)	IL59524A (da)
IT (1)	IT1218420B (da)
KE (1)	KE3467A (da)
LU (1)	LU82224A1 (da)
MY (1)	MY8500285A (da)
NL (1)	NL182959C (da)
NO (1)	NO152217C (da)
NZ (1)	NZ193052A (da)
PH (1)	PH15198A (da)
PL (1)	PL128296B1 (da)
PT (1)	PT70914A (da)
SE (1)	SE440778B (da)
SG (1)	SG67284G (da)
SU (1)	SU1277894A3 (da)
YU (1)	YU41911B (da)
ZA (1)	ZA801328B (da)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4414159A (en) *	1980-09-26	1983-11-08	E. I. Du Pont De Nemours & Co.	Vinyl ether monomers and polymers therefrom
US4444775A (en) *	1981-06-22	1984-04-24	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridines
KR840000529A (ko) *	1981-07-07	1984-02-25	콘스탄틴 루이스 클레멘트	인돌 유도체의 제조방법
ZA825413B (en) *	1981-08-26	1983-06-29	Pfizer	Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them
US4460777A (en) *	1981-11-19	1984-07-17	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4478842A (en) *	1981-11-19	1984-10-23	Ciba-Geigy Corporation	N-Substituted-2-pyridylindoles
US4539410A (en) *	1982-09-30	1985-09-03	Ciba-Geigy Corporation	N-Substituted-2-(1-imidazolyl)indoles
US4436746A (en)	1982-09-30	1984-03-13	Ciba-Geigy Corporation	Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
AT376436B (de) *	1982-11-05	1984-11-26	Laevosan Gmbh & Co Kg	Verfahren zur herstellung neuer thiophen-2carbons[urederivate und pharmazeutisch vertraeglicher saeure- oder basenadditionssalze davon
US4511573A (en) *	1983-05-17	1985-04-16	Ciba-Geigy Corporation	3-Substituted-2-(heteroaryl) indoles
ATE90076T1 (de)	1986-03-27	1993-06-15	Merck Frosst Canada Inc	Tetrahydrocarbazole ester.
JPH0832679B2 (ja) *	1986-09-05	1996-03-29	理化学研究所	Ｎ―フタルイシド誘導体及びその製造法
GR871809B (en) *	1986-11-28	1988-03-07	Glaxo Group Ltd	Process for the preparation of tricyclic ketones
EP0427860A1 (en) *	1989-03-31	1991-05-22	Kyoto Pharmaceutical Industries, Ltd.	New imidazole derivatives, production thereof, and uses thereof as medicines
CZ288351B6 (en) *	1990-06-07	2001-05-16	Astrazeneca Ab	Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
DE4023215A1 (de) *	1990-07-21	1992-01-23	Hoechst Ag	Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung
JPH06500551A (ja) *	1990-09-13	1994-01-20	ビーチャム・グループ・パブリック・リミテッド・カンパニー	５ｈｔ受容体アンタゴニストとしてのインドールウレア
US5162337A (en) *	1990-10-05	1992-11-10	Merck & Co., Inc.	Animal growth promotion
US5120749A (en) *	1991-02-20	1992-06-09	Abbott Laboratories	Platelet activating antagonists
DE69212844T2 (de) *	1991-12-18	1997-01-09	Schering Corp., Kenilworth, N.J.	Imidazolyl oder imidazolylalkyl substituiert mit einem 4- oder 5-gliedrigen stickstoff enthaltenden heterozyklischen ring
EP0597112A4 (en) *	1992-03-27	1994-06-22	Kyoto Pharma Ind	Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor.
US5538973A (en) *	1992-03-27	1996-07-23	Kyoto Pharmaceutical Industries, Ltd.	Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
JPH0632913U (ja) *	1992-09-18	1994-04-28	三洋電機株式会社	床暖房用パネル
AP2000001929A0 (en) *	1998-03-31	2000-09-30	Inst For Pharm Discovery Inc	Substituted indolealkanoic acids.
WO2004024726A1 (en) *	2002-09-12	2004-03-25	F. Hoffmann-La Roche Ag	N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
DE60323130D1 (de) *	2002-11-25	2008-10-02	Hoffmann La Roche	Indolderivaten
EP1569899B1 (en) *	2002-12-10	2006-06-28	Wyeth	Substituted 3-alkyl- and 3-arylalkyl-1h-indol-1-yl-acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
GB0324763D0 (en) *	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
MXPA06012683A (es) *	2004-05-03	2007-01-16	Hoffmann La Roche	Derivados de indolilo como moduladores de receptor x del higado.
MX2007004525A (es) *	2004-10-12	2007-09-19	Decode Genetics Inc	Sulfonamidas biciclicas peri-sustituidas para enfermedad de arteria oclusiva.
RU2008110908A (ru) *	2005-08-25	2009-09-27	Шеринг Корпорейшн (US)	Производные имидазола в качестве функционально селективных агонистов альфа2с адренорецепторов
US8399666B2 (en) *	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) *	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
CA2652152A1 (en) *	2006-05-16	2007-11-29	Decode Genetics Ehf	Process for preparing 7-(acryloyl)indoles
ES2391671T3 (es)	2006-07-22	2012-11-28	Oxagen Limited	Compuestos con actividad antagonista de CRTH2
TW200920369A (en) *	2007-10-26	2009-05-16	Amira Pharmaceuticals Inc	5-lipoxygenase activating protein (flap) inhibitor
EP2234608A2 (en)	2007-12-11	2010-10-06	Viamet Pharmaceuticals, Inc.	Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
DK2250161T3 (da)	2008-01-18	2014-01-27	Atopix Therapeutics Ltd	Forbindelser med CRTH2-antagonistaktivitet
US7750027B2 (en) *	2008-01-18	2010-07-06	Oxagen Limited	Compounds having CRTH2 antagonist activity
EP2240444A1 (en) *	2008-01-22	2010-10-20	Oxagen Limited	Compounds having crth2 antagonist activity
WO2009093026A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
JP5791500B2 (ja) *	2008-05-23	2015-10-07	パンミラファーマシューティカルズ，エルエルシー．	５−リポキシゲナーゼ活性化タンパク質阻害剤
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
EP2739144A4 (en) *	2011-06-20	2015-04-01	Alzheimer S Inst Of America Inc	COMPOUNDS AND ITS THERAPEUTIC USE
GB201322273D0 (en)	2013-12-17	2014-01-29	Atopix Therapeutics Ltd	Process
GB201407807D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
GB201407820D0 (en)	2014-05-02	2014-06-18	Atopix Therapeutics Ltd	Polymorphic form
WO2019191410A1 (en) *	2018-03-29	2019-10-03	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Inhibitors for the β-catenin / t-cell factor protein–protein interaction

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL125443C (da) *	1963-06-06
US3370063A (en) *	1964-10-05	1968-02-20	Mcneilab Inc	Substituted dimethoxy indoles and method of making the same
US3621027A (en) *	1968-03-18	1971-11-16	Endo Lab	1-aminoalkyl-2,6-diaryl 4,5,6,7 tetrahydro-4-oxindales
US3931229A (en) *	1973-08-23	1976-01-06	Warner-Lambert Company	3-Thiomethyl-2[2-(dialkylamino)ethyl]indoles
US4059583A (en) *	1975-11-13	1977-11-22	Mcneil Laboratories, Incorporated	Substituted indoles
AU523536B2 (en) *	1977-08-26	1982-08-05	Wellcome Foundation Limited, The	Imidazoles and methods of preparing them
US4140858A (en) *	1977-12-19	1979-02-20	Warner-Lambert Company	3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
EP0003901B1 (en) *	1978-02-24	1981-08-05	Pfizer Limited	3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

1980
- 1980-01-31 DK DK042580A patent/DK151884C/da active
- 1980-03-04 HU HU80498A patent/HU184727B/hu not_active IP Right Cessation
- 1980-03-04 CS CS801492A patent/CS253702B2/cs unknown
- 1980-03-05 ES ES489220A patent/ES489220A0/es active Granted
- 1980-03-05 LU LU82224A patent/LU82224A1/fr unknown
- 1980-03-05 IL IL59524A patent/IL59524A/xx unknown
- 1980-03-05 SU SU802891745A patent/SU1277894A3/ru active
- 1980-03-05 FI FI800672A patent/FI66860C/fi not_active IP Right Cessation
- 1980-03-05 PL PL1980222470A patent/PL128296B1/pl unknown
- 1980-03-05 GR GR61368A patent/GR67237B/el unknown
- 1980-03-05 NZ NZ193052A patent/NZ193052A/en unknown
- 1980-03-05 SE SE8001736A patent/SE440778B/sv not_active IP Right Cessation
- 1980-03-05 US US06/127,298 patent/US4273782A/en not_active Expired - Lifetime
- 1980-03-05 PH PH23726A patent/PH15198A/en unknown
- 1980-03-05 YU YU614/80A patent/YU41911B/xx unknown
- 1980-03-06 AU AU56231/80A patent/AU516957B2/en not_active Ceased
- 1980-03-06 FR FR8005054A patent/FR2450832A1/fr active Granted
- 1980-03-06 ZA ZA00801328A patent/ZA801328B/xx unknown
- 1980-03-06 NL NLAANVRAGE8001351,A patent/NL182959C/xx not_active IP Right Cessation
- 1980-03-06 PT PT70914A patent/PT70914A/pt not_active IP Right Cessation
- 1980-03-06 IT IT20399/80A patent/IT1218420B/it active
- 1980-03-06 IE IE453/80A patent/IE49542B1/en not_active IP Right Cessation
- 1980-03-06 CH CH1781/80A patent/CH649546A5/de not_active IP Right Cessation
- 1980-03-06 BE BE0/199699A patent/BE882113A/fr not_active IP Right Cessation
- 1980-03-06 KR KR1019800000931A patent/KR850000760B1/ko not_active Expired
- 1980-03-06 AT AT0125780A patent/AT375366B/de not_active IP Right Cessation
- 1980-03-06 CA CA000347143A patent/CA1120479A/en not_active Expired
- 1980-03-06 DD DD80219495A patent/DD149525A5/de not_active IP Right Cessation
- 1980-03-06 DE DE19803008632 patent/DE3008632A1/de active Granted
- 1980-03-06 NO NO800650A patent/NO152217C/no unknown
- 1980-03-06 AR AR280198A patent/AR227015A1/es active
- 1980-03-06 JP JP2856380A patent/JPS55133380A/ja active Granted
- 1980-11-14 ES ES496889A patent/ES496889A0/es active Granted
1984
- 1984-09-21 SG SG67284A patent/SG67284G/en unknown
- 1984-10-05 KE KE3467A patent/KE3467A/xx unknown
- 1984-11-15 HK HK898/84A patent/HK89884A/xx unknown
1985
- 1985-12-30 MY MY285/85A patent/MY8500285A/xx unknown

Also Published As

Publication number	Publication date
SE8001736L (sv)	1980-09-08
ES8104278A1 (es)	1981-04-01
IT1218420B (it)	1990-04-19
NO800650L (no)	1980-09-08
NL182959C (nl)	1988-06-16
NO152217C (no)	1985-08-21
NZ193052A (en)	1984-07-06
AT375366B (de)	1984-07-25
BE882113A (fr)	1980-09-08
SU1277894A3 (ru)	1986-12-15
AU516957B2 (en)	1981-07-02
IL59524A0 (en)	1980-06-30
HU184727B (en)	1984-10-29
PL222470A1 (da)	1980-12-01
KR830001928A (ko)	1983-05-19
SG67284G (en)	1985-03-15
ZA801328B (en)	1981-03-25
YU61480A (en)	1983-12-31
SE440778B (sv)	1985-08-19
IL59524A (en)	1982-11-30
FR2450832A1 (fr)	1980-10-03
NL8001351A (nl)	1980-09-09
ES8205789A1 (es)	1982-08-01
PT70914A (en)	1980-04-01
LU82224A1 (fr)	1980-06-06
ES496889A0 (es)	1982-08-01
DK151884B (da)	1988-01-11
DK42580A (da)	1980-09-08
DE3008632C2 (da)	1988-02-25
GR67237B (da)	1981-06-25
DD149525A5 (de)	1981-07-15
KR850000760B1 (ko)	1985-05-25
FI800672A7 (fi)	1980-09-08
KE3467A (en)	1984-11-09
CS253702B2 (en)	1987-12-17
ES489220A0 (es)	1981-04-01
JPS55133380A (en)	1980-10-17
MY8500285A (en)	1985-12-31
IT8020399A0 (it)	1980-03-06
JPS6141513B2 (da)	1986-09-16
PH15198A (en)	1982-09-17
HK89884A (en)	1984-11-23
PL128296B1 (en)	1984-01-31
AR227015A1 (es)	1982-09-15
FR2450832B1 (da)	1983-04-22
FI66860C (fi)	1984-12-10
ATA125780A (de)	1983-12-15
DE3008632A1 (de)	1980-10-16
AU5623180A (en)	1980-09-11
US4273782A (en)	1981-06-16
CA1120479A (en)	1982-03-23
CH649546A5 (de)	1985-05-31
IE49542B1 (en)	1985-10-30
IE800453L (en)	1980-09-07
FI66860B (fi)	1984-08-31
NO152217B (no)	1985-05-13
YU41911B (en)	1988-02-29

Publication	Publication Date	Title
DK151623C (da)	1988-07-18	Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK147362C (da)	1988-06-27	Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK151331C (da)	1988-04-25	Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK149308C (da)	1986-12-08	Analogifremgangs-maade til fremstilling af trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater eller farmaceutisk acceptablesyreadditionssalte deraf
DK162714C (da)	1992-04-21	Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf
DK149895C (da)	1987-04-21	Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK164545C (da)	1992-11-30	Analogifremgangsmaade til fremstilling af sulfonylamino- eller sulfonylaminoalkylphenoxyalkylcarbonsyrederivater eller fysiologisk uskadelige salte deraf
DK149630C (da)	1987-01-26	Analogifremgangsmaade til fremstilling af tripeptidamider eller -estere eller fysiologisk acceptable syreadditionssalte deraf
DK151017C (da)	1988-06-13	Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK149569C (da)	1987-02-02	Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf
DK157862C (da)	1990-08-06	Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK154950C (da)	1989-05-29	Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK158658C (da)	1990-12-31	Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK142544C (da)	1981-08-17	Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf
DK149841C (da)	1987-04-21	Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK149077C (da)	1986-06-16	Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK146066C (da)	1983-11-14	Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf
DK151805C (da)	1988-06-13	Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK152427C (da)	1988-07-25	Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK165005C (da)	1993-02-08	Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK144793C (da)	1982-11-01	Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK160874C (da)	1992-02-24	Analogifremgangsmaade til fremstilling af ergol-8-en- eller ergolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK152208C (da)	1988-08-08	Analogifremgangsmaade til fremstilling af 2-phenylamino-phenyleddikesyreamider eller farmaceutisk acceptable salte deraf
DK157023C (da)	1990-03-19	Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK152211C (da)	1988-08-08	Analogifremgangsmaade til fremstilling af n-phenyl-n-(4-piperidinyl)-amider eller farmaceutisk acceptable syreadditionssalte deraf.